DESI1 and cancer: DESI1 is required for the activity of FoxM1 in the transcription of mitotic regulators including Aurora B. Lower levels of DESI1 in cancer cells are associated with poorer prognosis of patients with endometrioid cancer and a decrease in sensitivity against microtubule‐targeting agents.